NO20073256L - Vaksiner mot meningococcus - Google Patents

Vaksiner mot meningococcus

Info

Publication number
NO20073256L
NO20073256L NO20073256A NO20073256A NO20073256L NO 20073256 L NO20073256 L NO 20073256L NO 20073256 A NO20073256 A NO 20073256A NO 20073256 A NO20073256 A NO 20073256A NO 20073256 L NO20073256 L NO 20073256L
Authority
NO
Norway
Prior art keywords
fragment
variant
vaccines against
against meningococcus
polypeptide
Prior art date
Application number
NO20073256A
Other languages
English (en)
Norwegian (no)
Inventor
Christoph Marcel Tang
Yanwen Li
Original Assignee
Imp Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2004/005441 external-priority patent/WO2005060995A2/fr
Application filed by Imp Innovations Ltd filed Critical Imp Innovations Ltd
Publication of NO20073256L publication Critical patent/NO20073256L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20073256A 2004-12-23 2007-06-25 Vaksiner mot meningococcus NO20073256L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/GB2004/005441 WO2005060995A2 (fr) 2003-12-23 2004-12-23 Vaccins
PCT/GB2005/005113 WO2006067518A2 (fr) 2004-12-23 2005-12-23 Vaccins et leur utilisation

Publications (1)

Publication Number Publication Date
NO20073256L true NO20073256L (no) 2007-09-17

Family

ID=36282716

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073256A NO20073256L (no) 2004-12-23 2007-06-25 Vaksiner mot meningococcus

Country Status (10)

Country Link
EP (1) EP1848457A2 (fr)
JP (1) JP2008525008A (fr)
KR (1) KR20070094762A (fr)
CN (2) CN101115502A (fr)
AU (1) AU2005317835A1 (fr)
CA (1) CA2592156A1 (fr)
MX (1) MX2007007886A (fr)
NO (1) NO20073256L (fr)
RU (1) RU2007127921A (fr)
WO (1) WO2006067518A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080090447A (ko) * 2005-12-23 2008-10-08 임페리얼 이노베이션스 리미티드 수막구균 백신 및 그의 용도

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9814902D0 (en) * 1998-07-10 1998-09-09 Univ Nottingham Screening of neisserial vaccine candidates against pathogenic neisseria

Also Published As

Publication number Publication date
CN101115502A (zh) 2008-01-30
WO2006067518A3 (fr) 2006-11-23
MX2007007886A (es) 2008-01-16
WO2006067518A2 (fr) 2006-06-29
RU2007127921A (ru) 2009-01-27
CN101370514A (zh) 2009-02-18
EP1848457A2 (fr) 2007-10-31
AU2005317835A1 (en) 2006-06-29
KR20070094762A (ko) 2007-09-21
JP2008525008A (ja) 2008-07-17
CA2592156A1 (fr) 2006-06-29

Similar Documents

Publication Publication Date Title
CY1106875T1 (el) Αντιγονικα πεπτιδια απο neisseria
NO20063026L (no) Antistoffer
WO2006076410A3 (fr) Vaccins peptidiques hybrides a base d'epitope antigenique/li -key
DK1645631T3 (da) Neisseria antigener og præparater
ATE397068T1 (de) Antigene meningokokken peptide
NO20050008L (no) Neisserial vaksinesammensetninger omfattende en kombinasjon av antigener
DE69841807D1 (de) Neisseriale antigene
ATE468127T1 (de) Ii-key/antigene epitop-hybrid-peptid-vakzine
EP1897555A3 (fr) Vaccin OMV complété contre la méningocoque
DK1904529T3 (da) Anvendelse af Stefin A som et scaffoldprotein
WO2009025117A1 (fr) Peptide cdca1 et agent pharmaceutique le comprenant
UA107330C2 (uk) Туберкульозний білок rv3616c та його застосування
DK1328547T3 (da) Identifikation og modifikation af immundominante epitoper i polypeptider
DE602004025943D1 (de) Mikrosomvakzin
ATE551069T1 (de) Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
ATE457352T1 (de) Subtilisin-carlsberg-proteine mit verminderter immunogenität
EP1932915A3 (fr) Matériaux et procédés associés à des stratégies de vaccination améliorées
WO2000012535A3 (fr) Polypeptide $i(neisseria meningitidis), sequence d'acide nucleique et utilisations associees
DK1214088T3 (da) Proteiner udtrykt af Mycobacterium tuberculosis og ikke af BCG og anvendelse heraf som diagnostiske reagenser og vacciner
NO20073256L (no) Vaksiner mot meningococcus
DK1913020T3 (da) Immunogene konstrukter
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
MY144766A (en) Plant virus coat fusion proteins with gdf8 epitopes and vaccines thereof
NO20082810L (no) Vaksine, og anvendelse av samme
NO20005081D0 (no) Et polypeptid inneholdende aminosyren fra et N-terminalt kolinbindende protein A-truncat, vaksine avledet derfra og anvendelser derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application